Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

LIRAGLUTIDE

LIRAGLUTIDE

Standard Dose
18MG/3ML (6MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LIRAGLUTIDE is listed in Drugs@FDA under application 218115 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LIRAGLUTIDE Form and strength SOLUTION;SUBCUTANEOUS - 18MG/3ML (6MG/ML) Sponsor NANJING KING FRIEND Submission history Latest submission status date: 2025-10-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview LIRAGLUTIDE is listed in Drugs@FDA under application 218115 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LIRAGLUTIDE Form and strength SOLUTION;SUBCUTANEOUS - 18MG/3ML (6MG/ML) Sponsor NANJING KING FRIEND Submission history Latest submission status date: 2025-10-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.